'Merger mania' could leave strategic CROs vulnerable in 2016, says PwC
Mergers among Big Pharma companies will continue into 2016 leaving strategic CRO partnerships at risk, according to a report from PwC.
Archives for January 5, 2016
FDA's bioequivalence rules are out of date and need to be modernised
Many generic drugs are not truly bioequivalent to the original medicines they copy and switching to them can lead to worse patient outcomes, according to US researchers.
Biologic makers looking to delivery devices to gain competitive edge, Bespak
Having a proactive approach to delivery technologies will give pharma firms a competitive edge against biosimilars and biobetters, according to device maker Bespak.
‘Smart wound dressing’ delivers drugs on-demand
MIT engineers have designed a new hydrogel material that can incorporate temperature sensors, LED lights, and other electronics – in addition to drug-delivering reservoirs.
Paragon launches manufacturing compliance service for drug firms
Paragon Solutions has rolled out a new service to help drugmakers make sure their manufacturing operations comply with US FDA regulations.